KATHERINE RUNYAN: Open Payments
NPI 1164813606 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56,067 in 278 payments from 20 companies in 2025. Trend: 2023 $23,385 · 2024 $45,733 · 2025 $56,067
Speaker / faculty: $35,350Travel & lodging: $12,785Food & beverage: $6,092Consulting: $1,740Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 62 | $15,456 |
| PFIZER INC. | 27 | $14,180 |
| ABBVIE INC. | 77 | $14,132 |
| UCB, Inc. | 26 | $8,148 |
| Janssen Biotech, Inc. | 17 | $2,232 |
| GENZYME CORPORATION | 7 | $422 |
| AstraZeneca Pharmaceuticals LP | 13 | $309 |
| Novartis Pharmaceuticals Corporation | 16 | $197 |
| Radius Health, Inc. | 4 | $175 |
| GlaxoSmithKline, LLC. | 9 | $167 |
Products named: KRYSTEXXA, XELJANZ, Bimzelx, RINVOQ, TREMFYA, KEVZARA, TAVNEOS, SAPHNELO.
Industry payments across TN — which companies pay providers there.
